1-800-526-8630
FEATURED COMPANIES
- Ascendance Bio
- Axosim
- CN Bio
- Emulate
- Hurel
- Insphero
- MORE
“The global organs-on-chips market projected to grow at a CAGR of 36.6%.”
Focus on developing alternatives for animal testing models, significant increase in research funding and venture capital investments for the development of organs-on-chips, technological advancements and products launches, growing number of partnerships and collaborations between pharmaceutical companies and organs-on-chips manufacturers, and growing need for early detection of drug toxicity to minimize financial losses due to late stage drug failure are some of the factors driving the growth of the market. On the other hand, issues related to the incorporation of organs-on-chips technologies into existing workflows, and complexity of organs-on-chips models may limit market growth to a certain extent in the coming years.
“Services segment are expected to hold the largest share of the market in 2017.”
Based on offering, the organs-on-chips market is segmented into products and services. The services segment is expected to dominate this market and is also expected to grow at the highest CAGR during the forecast period. The dearth of skilled professionals and the lack of the necessary R&D infrastructure to handle and interpret results obtained by using OOC systems, coupled with the increasing research outsourcing by pharmaceutical and biotechnology companies are driving the high growth of the services segment.
“The toxicology research segment is expected to dominate the market during the forecast period.”
Based on application, the market is segmented into physiological model development, drug discovery, and toxicology research. The toxicology research segment is expected to dominate the market during the forecast period. The increasing efforts for replacing animal toxicity studies by developing more efficient and accurate alternatives are expected to drive the growth of the toxicology research segment during the forecast period.
“North America to witness high growth during the forecast period.”
In 2017, North America is expected to account for the largest share and also expected to grow at the highest CAGR of the market followed by Europe. The largest share and high growth of this market is attributed to factors such as the availability of new and advanced organs-on-chips models in the market, favorable government initiatives in terms of funding and programs for basic drug development and research, and the presence of key pharmaceutical companies.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type: Tier 1 - 25%; Tier 2 - 30%; Tier 3 - 45%.
- By Designation: C-level- 25%; D-level- 40%; others- 35%.
- By Region: North America-41%; Europe-30%; Asia-24%; RoW: 5%
List of companies profiled in the report
- CN Bio (UK)
- Emulate (US)
- TissUse (Germany)
- Mimetas (Netherlands)
- InSphero (Switzerland)
- Ascendance Bio (US)
- Kirkstall (UK)
- HUREL (US)
- SynVivo (US)
- AxoSim (US)
- Nortis (US)
Research Coverage:
The report provides an overview of the organs-on-chips market. It aims at estimating the market size and future growth potential of this market across different segments such as type, offerings, application, end user, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market by providing them with the closest approximations of revenues for the overall organs-on-chips market and its subsegments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies make suitable go-to-market strategies. The report also will also help stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.
FEATURED COMPANIES
- Ascendance Bio
- Axosim
- CN Bio
- Emulate
- Hurel
- Insphero
- MORE
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Market Stakeholders
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Secondary Sources
2.1.2 Primary Data
2.1.2.1 Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study
3 Executive Summary
4 Premium Insights
4.1 Organs-on-Chips Market Overview
4.2 Europe: Organs-on-Chips Market, By Application & Country
4.3 Organs-on-Chips Market, By Type
4.4 Organs-on-Chips Market, By Application
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Focus on Developing Alternatives for Animal Testing Models
5.2.1.2 Significant Increase in Research Funding and Venture Capital Investments for the Development of Organs-on-Chips
5.2.1.3 Technological Advancements and New Products Launches
5.2.1.4 Growing Number of Partnerships and Collaborations Between Pharmaceutical Companies and Organs-on-Chips Manufacturers
5.2.1.5 Growing Need for Early Detection of Drug Toxicity to Minimize Financial Losses Due to Late Stage Drug Failure
5.2.1.6 Growing Initiatives to Increase Awareness About Organs-on-Chips Technologies
5.2.2 Restraint
5.2.2.1 Issues Related to the Incorporation of Organs-on-Chips Technologies Into Existing Workflows
5.2.3 Opportunities
5.2.3.1 Increasing Focus on Drug Discovery Activities
5.2.3.2 Application of Organs-on-Chips in Oncology Research
5.2.3.3 Development of Multiple-Organs-on-A-Chip Models
5.2.4 Challenges
5.2.4.1 Complexity of Organs-on-Chips Models
5.2.4.2 Dearth of Skilled Professionals
5.3 Funding and Venture Capital Investments
6 Organs-on-Chips Market, By Type
6.1 Introduction
6.2 Liver
6.3 Heart
6.4 Lung
6.5 Kidney
6.6 Other Organs
7 Organs-on-Chips Market, By Offering
7.1 Introduction
7.2 Products
7.3 Services
8 Organs-on-Chips Market, By Application
8.1 Introduction
8.2 Physiological Model Development
8.3 Drug Discovery
8.4 Toxicology Research
9 Organs-on-Chips Market, By End User
9.1 Introduction
9.2 Pharmaceutical & Biotechnology Companies
9.3 Academic & Research Institutes
9.4 Cosmetics Industry
9.5 Other End Users
10 Organs-on-Chips Market, By Region
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 RoE
10.4 Asia
10.5 Rest of the World
11 Competitive Landscape
11.1 Overview
11.2 Ranking of Players, 2016
11.3 Competitive Situation and Trends
11.3.1 Agreements, Partnerships, and Collaborations
11.3.2 Product Launches
11.3.3 Expansions
12 Company Profiles
(Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, Recent Developments)*
12.1 Emulate
12.2 CN Bio
12.3 Tissuse
12.4 Mimetas
12.5 Insphero
12.6 Ascendance Bio
12.7 Kirkstall
12.8 Hurel
12.9 Synvivo
12.10 Axosim
12.11 Nortis
*Details on View, Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, and Recent Developments Might Not Be Captured in Case of Unlisted Companies.
13 Appendix
13.1 Insights From Industry Experts
13.2 Discussion Guide
13.3 Knowledge Store: Subscription Portal
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports
13.7 Author Details
List of Tables
Table 1 Key Product Launches/Upgrades
Table 2 Funding & Venture Capital Investments
Table 3 Organs-on-Chips Market, By Type, 2015–2022 (USD Million)
Table 4 Liver-on-A-Chip Market, By Region, 2015–2022 (USD Thousand)
Table 5 North America: Liver-on-A-Chip Market, By Country, 2015–2022 (USD Thousand)
Table 6 Heart-on-A-Chip Market, By Region, 2015–2022 (USD Thousand)
Table 7 North America: Heart-on-A-Chip Market, By Country, 2015–2022 (USD Thousand)
Table 8 Lung-on-A-Chip Market, By Region, 2015–2022 (USD Thousand)
Table 9 North America: Lung-on-A-Chips Market, By Country, 2015–2022 (USD Thousand)
Table 10 Kidney-on-A-Chip Market, By Region, 2015–2022 (USD Thousand)
Table 11 North America: Kidney-on-A-Chip Market, By Country, 2015–2022 (USD Thousand)
Table 12 Other Organs-on-Chips Market, By Region, 2015–2022 (USD Thousand)
Table 13 North America: Other Organs-on-Chips Market, By Country, 2015–2022 (USD Thousand)
Table 14 Organs-on-Chips Market, By Offering, 2015–2022 (USD Million)
Table 15 North America: Organs-on-Chips Products Market, By Country, 2015–2022 (USD Thousand)
Table 16 North America: Organs-on-Chips Services Market, By Country, 2015–2022 (USD Thousand)
Table 17 Organs-on-Chips Market, By Application, 2015–2022 (USD Million)
Table 18 Organs-on-Chips Market for Physiological Model Development, By Region, 2015–2022 (USD Thousand)
Table 19 North America: Organs-on-Chips Market for Physiological Model Development, By Country, 2015–2022 (USD Thousand)
Table 20 Europe: Organs-on-Chips Market for Physiological Model Development, By Country, 2015–2022 (USD Thousand)
Table 21 Organs-on-Chips Market for Drug Discovery, By Region, 2015–2022 (USD Thousand)
Table 22 North America: Organs-on-Chips Market for Drug Discovery, By Country, 2015–2022 (USD Thousand)
Table 23 Europe: Organs-on-Chips Market for Drug Discovery, By Country, 2015–2022 (USD Thousand)
Table 24 Organs-on-Chips Market for Toxicology Research, By Region, 2015–2022 (USD Thousand)
Table 25 North America: Organs-on-Chips Market for Toxicology Research, By Country, 2015–2022 (USD Thousand)
Table 26 Europe: Organs-on-Chips Market for Toxicology Research, By Country, 2015–2022 (USD Thousand)
Table 27 Organs-on-Chips Market, By End User, 2015–2022 (USD Million)
Table 28 Organs-on-Chips Market for Pharmaceutical & Biotechnology Companies, By Region, 2015–2022 (USD Thousand)
Table 29 North America: Organs-on-Chips Market for Pharmaceutical & Biotechnology Companies, By Country, 2015–2022 (USD Thousand)
Table 30 Europe: Organs-on-Chips Market for Pharmaceutical & Biotechnology Companies, By Country, 2015–2022 (USD Thousand)
Table 31 Organs-on-Chips Market for Academic & Research Institutes, By Region, 2015–2022 (USD Thousand)
Table 32 North America: Organs-on-Chips Market for Academic & Research Institutes, By Country, 2015–2022 (USD Thousand)
Table 33 Europe: Organs-on-Chips Market for Academic & Research Institutes, By Country, 2015–2022 (USD Thousand)
Table 34 Organs-on-Chips Market for Cosmetics Industry, By Region, 2015–2022 (USD Thousand)
Table 35 North America: Organs-on-Chips Market for Cosmetics Industry, By Country, 2015–2022 (USD Thousand)
Table 36 Europe: Organs-on-Chips Market for Cosmetics Industry, By Country, 2015–2022 (USD Thousand)
Table 37 Organs-on-Chips Market for Other End Users, By Region, 2015–2022 (USD Thousand)
Table 38 North America: Organs-on-Chips Market for Other End Users, By Country, 2015–2022 (USD Thousand)
Table 39 Europe: Organs-on-Chips Market for Other End Users, By Country, 2015–2022 (USD Thousand)
Table 40 Organs-on-Chips Market, By Region, 2015–2022 (USD Million)
Table 41 North America: Organs-on-Chips Market, By Country, 2015–2022 (USD Thousand)
Table 42 North America: Organs-on-Chips Market, By Type, 2015–2022 (USD Thousand)
Table 43 North America: Organs-on-Chips Market, By Offering, 2015–2022 (USD Thousand)
Table 44 North America: Organs-on-Chips Market, By Application, 2015–2022 (USD Thousand)
Table 45 North America: Organs-on-Chips Market, By End User, 2015–2022 (USD Thousand)
Table 46 US: Organs-on-Chips Market, By Offering, 2015–2022 (USD Thousand)
Table 47 US: Organs-on-Chips Market, By Application, 2015–2022 (USD Million)
Table 48 US: Organs-on-Chips Market, By End User, 2015–2022 (USD Thousand)
Table 49 Canada: Organs-on-Chips Market, By Offering, 2015–2022 (USD Thousand)
Table 50 Canada: Organs-on-Chips Market, By Application, 2015–2022 (USD Thousand)
Table 51 Canada: Organs-on-Chips Market, By End User, 2015–2022 (USD Thousand)
Table 52 Europe: Organs-on-Chips Market, By Country, 2015–2022 (USD Thousand)
Table 53 Europe: Organs-on-Chips Market, By Type, 2015–2022 (USD Thousand)
Table 54 Europe: Organs-on-Chips Market, By Offering, 2015–2022 (USD Thousand)
Table 55 Europe: Organs-on-Chips Market, By Application, 2015–2022 (USD Thousand)
Table 56 Europe: Organs-on-Chips Market, By End User, 2015–2022 (USD Thousand)
Table 57 Germany: Organs-on-Chips Market, By Application, 2015–2022 (USD Thousand)
Table 58 Germany: Organs-on-Chips Market, By End User, 2015–2022 (USD Thousand)
Table 59 UK: Organs-on-Chips Market, By Application, 2015–2022 (USD Thousand)
Table 60 UK: Organs-on-Chips Market, By End User, 2015–2022 (USD Thousand)
Table 61 RoE: Organs-on-Chips Market, By Application, 2015–2022 (USD Thousand)
Table 62 RoE: Organs-on-Chips Market, By End User, 2015–2022 (USD Thousand)
Table 63 Asia: Organs-on-Chips Market, By Type, 2015–2022 (USD Thousand)
Table 64 Asia: Organs-on-Chips Market, By Application, 2015–2022 (USD Thousand)
Table 65 Asia: Organs-on-Chips Market, By End User, 2015–2022 (USD Thousand)
Table 66 RoW: Organs-on-Chips Market, By Application, 2015–2022 (USD Thousand)
Table 67 RoW: Organs-on-Chips Market, By End User, 2015–2022 (USD Thousand)
Table 68 Organs-on-Chips Market Ranking Analysis, By Key Player (2016)
List of Figures
Figure 1 Research Design
Figure 2 Bottom-Up Approach
Figure 3 Top-Down Approach
Figure 4 Break Down of Primary Interviews: By Company, Designation, and Region
Figure 5 Data Triangulation Methodology
Figure 6 Liver-on-A-Chip Market to Grow at the Highest Rate During the Forecast Period
Figure 7 Services Segment to Witness Highest Growth During the Forecast Period
Figure 8 Drug Discovery Segment to Register the Highest Rate During the Forecast Period
Figure 9 Pharmaceutical & Biotechnology Companies to Dominate the Organs-on-Chips End-User Market During the Forecast Period
Figure 10 North America to Witness Highest Growth During the Forecast Period (2017–2022)
Figure 11 Focus on Developing Alternatives to Animal Testing to Drive the Growth of the Market
Figure 12 Toxicology Research to Hold the Largest Share of the Organs-on-Chips Market in Europe(2017)
Figure 13 Liver Segment to Witness High Growth From 2017 to 2022
Figure 14 Toxicology Research Segment to Dominate the Organs-on-Chips Market in 2017
Figure 15 Organs-on-Chips Market: Drivers, Restraints, Opportunities, and Challenges
Figure 16 Number of Registered Clinical Trial Studies (2005–2017)
Figure 17 Liver Segment to Dominate the Organs-on-Chips Market During the Forecast Period
Figure 18 Services Segment to Dominate the Organs-on-Chips Market During the Forecast Period
Figure 19 Toxicology Research is Estimated to Be the Largest Application Segment in the Organs-on-Chips Market
Figure 20 Pharmaceutical & Biotechnology Companies Will Continue to Dominate the Organs-on-Chips Market in 2022
Figure 21 North America Will Continue to Dominate the Organs-on-Chips Market in 2022
Figure 22 North America: Organs-on-Chips Market Snapshot
Figure 23 Europe: Organs-on-Chips Market Snapshot
Figure 24 Asia: Organs-on-Chips Market Snapshot
Figure 25 RoW: Organs-on-Chips Market Snapshot
Figure 26 Strategies Adopted By Market Players (2014–2017)
Figure 27 Market Evolution Framework
LOADING...
FEATURED COMPANIES
- Ascendance Bio
- Axosim
- CN Bio
- Emulate
- Hurel
- Insphero
- MORE
The organs-on-chips market is expected to reach USD 45.6 Million by 2022 from USD 9.6 Million in 2017, at a CAGR of 36.6%. The growth of this market is mainly driven by the growing focus on developing alternatives for animal testing models, significant increase in research funding and venture capital investments for the development of organs-on-chips, technological advancements and new products launches, growing number of partnerships and collaborations between pharmaceutical companies and organs-on-chips manufacturers, and growing need for early detection of drug toxicity to minimize financial losses due to late stage drug failure.
This report segments the organs-on-chips market into type, offerings, application, end user, and region. Based on type, the organs-on-chips market is segmented into liver, lung, heart, kidney, and other organs-on-chips. In 2017, the accessories segment is expected to account for the largest share of the organs-on-chips market. The large share of this segment can be attributed to the simplicity of this model and the ability of on-chip hepatic tissues to maintain metabolic activity and phenotype similar to the in vivo environment.
Based on application, the organs-on-chips market is segmented into physiological model development, drug discovery, and toxicology research. The drug discovery segment is expected to register the highest CAGR during the forecast period.
In 2017, North America is expected to account for the largest share and also expected to grow at the highest CAGR of the market followed by Europe. The largest share and high growth of this market is attributed to the factors such as the availability of new and advanced organs-on-chips models in the market, favorable government initiatives in terms of funding and programs for basic drug development and research, and the presence of key pharmaceutical companies.
Issues related to the incorporation of organs-on-chips technologies into existing workflows, and complexity of organs-on-chips models may limit market growth to a certain extent in the coming years. The organs-on-chips market is emerging and competitive in nature, with a number of small players competing for market space (including startups firms). Prominent players in this market include Mimetas (Netherlands), Emulate (US), InSphero (Switzerland), Ascendance Bio (US), CN Bio (UK), TissUse (Germany), Kirkstall (UK), HUREL (HUREL) (US), SynVivo (US), AxoSim (US), and Nortis (US).
- Ascendance Bio
- Axosim
- CN Bio
- Emulate
- Hurel
- Insphero
- Kirkstall
- Mimetas
- Nortis
- Synvivo
- Tissuse
![Worldwide Organ on a Chip (OOC) Market [by Segments (Devices, Services); by Types (Lung, Heart, Liver, Intestine, Kidney, Human, Placenta, Gut, Nerve, Others); by Regions (North America, Europe, APAC, CALA, MEA)]: Sizes and Forecasts (2018-2023) - Product Image](http://d386vep05x5edh.cloudfront.net/product_images/6968/6968483_60px_jpg/worldwide_organ_on_a_chip_ooc_market_[by.jpg)
